Health Policy Advocacy & Market Access
Bernstein Health is a strategy consultancy firm for market access and health policy advocacy. Our team of experienced experts interweaves these two strands and knows the relevant issues, procedures and actors in detail. We offer customized solutions and create synergies for our clients through our integrated consulting approach.
A holistic approach that creates meaningful synergies
The integration of political lobbying and market access creates impact. We develop holistic strategies for pharmaceutical companies, care providers and other actors in the healthcare system at the interface between politics and the public, based on data, facts and findings.
Many years of experience and a resilient network
Rooted in Berlin and with excellent networks in Brussels and the federal states: our team has many years of experience in advising companies for whom legislation and communication are critical to success – in regulatory decisions, marketing approval or reimbursement of costs.
Integrated consulting to achieve strategic goals
Bernstein Health helps companies in the healthcare industry to successfully introduce their products in Germany. We follow health policy developments and advocate our clients’ interests in the political process. We offer effective, tailor-made services to implement the strategic goals of our clients.
We bring market access and political advocacy together
The interactions between health policy decisions and the procedures for introducing new medical products into the healthcare market are becoming increasingly important. Joining both together is essential for appropriate and patient-oriented care.
The healthcare system is changing
The healthcare system and the way in which health policy is made are undergoing lasting change. Political decision-makers and opinion leaders are increasingly thinking in terms of larger health policy guidelines. The healthcare system is becoming more political and the opportunities to help shape decision-making processes are becoming more diverse.
Covid-19 reveals the strengths and weaknesses of the system.
The pandemic is placing unprecedented demands on the healthcare system and the (health-related) political stakeholders. Covid-19 is challenging the established system. Politicians must find a way to strengthen resilience against this and upcoming pandemics while remaining efficient.
Personalized therapies require a new framework
ATMPs, personalized therapies and pharmaceuticals offer unprecedented opportunities for treating illnesses by allowing them to be tailored to individual patients. These new opportunities are also associated with new health-economic and regulatory challenges.
Cost pressure and efficiency requirements are increasing considerably.
Payers are being forced to control and limit their expenditure, and not only because of the Covid-19 crisis. The high prices for advanced therapies place a major burden on health insurance companies and are leading to financial and ethical debates. Proving the efficacy of a therapy is becoming even more important.
Market access & strategy
We identify barriers to market access and use proven methods to overcome them. We develop strategies to overcome challenges for patient access to therapies.
Price negotiations & reimbursement
We develop solutions for price negotiations in the self-management system. We analyze evidence requirements to accompany our clients every step of the way.
Political advocacy
We are conversant with German health policy and decision-making process-es. We are connected to relevant stakeholders in Berlin, Brussels and the federal states. We are actively involved in shaping health policy debates.
Corporate communications
We generate media attention for our clients’ issues. We position them in the media outlets that are relevant to them. We supplement political strategies with targeted media coverage.
Two experienced consulting firms join forces
Bernstein Health is a 50/50 joint venture that brings together a wide range of expertise. We create modern health policy frameworks and pave the way for innovative therapies and medical services.
Founders
Sven Rawe
Co-Founder, Bernstein Group
Julia Spitze
Co-Founder, Bernstein Group
Julia Spitze manages the business of the Bernstein Group, which, in addition to political advocacy, also offers corporate communications and data-driven political analyses. She has been advising companies and associations on their positioning in the political arena and developing political strategies for more than 15 years.
(DE) Johannes Heuser
Director
(DE) Johannes Heuser verantwortet als Director den Ausbau der Bernstein Health. Er ist Public Affairs- und Kommunikationsexperte mit langjähriger Erfahrung im Gesundheitssektor. Vor seiner Zeit bei der Bernstein Health baute er die Gesundheits-Practice einer strategischen Kommunikationsberatung auf. Er berät Unternehmen bei der Marktzulassung, der strategischen Positionierung und bei der Vertretung politischer Interessen im Gesundheitssektor.
+49 (0) 172 316 533 2
heuser@bernstein-health.de
Dr. Philipp Mauch
Co-Founder, PIVOT Regulatory
Alexander Hinz
Co-Founder, PIVOT Regulatory
Alexander Hinz’s main focus is on regulatory analytics. This concerns the analysis and assessment of regulation on consumers, companies and markets. Prior to founding Pivot, he worked at PricewaterhouseCoopers, Philip Morris International and Bayer MaterialScience in the areas of product regulation, product safety and EHS-related risk management.
Perspectives
Current standpoints, assessments, and debate contributions from the Bernstein Health team.
Blog
-
The European Health Data Space and its Opportunity for Improving Quality of Care
A key component of the European Health Union is the European Health Data Space (EHDS), which was launched by the European Commission at the beginning of May. It is one of twelve data spaces which is inteded to facilitate data exchange in the EU. The European Health Data Space is to allow efficient exchange and direct access to different health data and has the chance to improve healthcare for European patients.
-
(DE) 5 Jahre „Cannabis als Medizin“- Gesetz: 5 Jahre Evidenzgewinn?
(DE) Ärzte, die Cannabisarzneimittel zulasten der gesetzlichen Krankenversicherung verschreiben, waren seit März 2017 dazu verpflichtet, an einer nichtinterventionellen Begleiterhebung zur Anwendung von Cannabisarzneimitteln teilzunehmen. Die Ergebnisse der Begleiterhebung sind Grundlage für den Gemeinsamen Bundesausschuss die zukünftige Übernahme der Behandlungskosten zu regeln. Was können Patienten, Pharmaunternehmen, Ärzte und Gesetzgeber von den Ergebnissen der Begleiterhebung erwarten?
-
(DE) Bernstein Health erhält neue Leitung: Johannes Heuser führt das Unternehmen ins neue Jahr
Sorry, this entry is only available in German.
Behind the scenes
Für mehr Perspektiven finden Sie uns auch auf LinkedIn
Career
You share our passion for health policy and market access? Become part of our team!
Contact
Berlin
Bernstein Health GmbH
Neustädtische Kirchstraße 6
10117 Berlin
Germany
+49 30 275 723 – 0
bernsteinhealth@bernstein-group.com
Imprint
For Bernstein Group, Analytics, Public Policy, Communications and Health:
Bernstein Communications GmbH
Neustädtische Kirchstraße 6
D-10117 Berlin
Phone: +49 30 275 723 -0
bernsteinhealth@bernstein-group.com
Management: Sven Rawe, Ralf Kunkel
AG Charlottenburg (Berlin)
HRB 182680 B
VAT Number: DE301067174
